Literature DB >> 33768625

Protein-Antibody Conjugates (PACs): A Plug-and-Play Strategy for Covalent Conjugation and Targeted Intracellular Delivery of Pristine Proteins.

Bin Liu1, Khushboo Singh1,2, Shuai Gong1,2, Mine Canakci3,2, Barbara A Osborne3,2,4, S Thayumanavan1,3,2.   

Abstract

We report here on protein-antibody conjugates (PACs) that are used for antibody-directed delivery of protein therapeutics to specific cells. PACs have the potential to judiciously combine the merits of two prolific therapeutic approaches-biologics and antibody-drug conjugates. We utilize spherical polymer brushes to construct PACs using the combination of two simple and efficient functionally orthogonal click chemistries. In addition to the synthesis and characterization of these nanoparticles, we demonstrate that PACs are indeed capable of specifically targeting cells based on the presence of target antigen on the cell surface to deliver proteins. The potentially broad adaptability of PACs opens up new opportunities for targeted biologics in therapeutics and sensing.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  antibody-targeted delivery; click chemistry; drug delivery; protein encapsulation; protein-antibody conjugates

Mesh:

Substances:

Year:  2021        PMID: 33768625      PMCID: PMC8762996          DOI: 10.1002/anie.202103106

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   16.823


  46 in total

Review 1.  Design of next-generation protein therapeutics.

Authors:  Justin Caravella; Alexey Lugovskoy
Journal:  Curr Opin Chem Biol       Date:  2010-07-16       Impact factor: 8.822

Review 2.  Protein therapeutics: a summary and pharmacological classification.

Authors:  Benjamin Leader; Quentin J Baca; David E Golan
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

3.  Labeling proteins on live mammalian cells using click chemistry.

Authors:  Ivana Nikić; Jun Hee Kang; Gemma Estrada Girona; Iker Valle Aramburu; Edward A Lemke
Journal:  Nat Protoc       Date:  2015-04-23       Impact factor: 13.491

Review 4.  Boronic acids as building blocks for the construction of therapeutically useful bioconjugates.

Authors:  João P M António; Roberto Russo; Cátia Parente Carvalho; Pedro M S D Cal; Pedro M P Gois
Journal:  Chem Soc Rev       Date:  2019-07-01       Impact factor: 54.564

5.  Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity.

Authors:  D Scott Wilson; Sachiko Hirosue; Michal M Raczy; Leonardo Bonilla-Ramirez; Laura Jeanbart; Ruyi Wang; Marcin Kwissa; Jean-Francois Franetich; Maria A S Broggi; Giacomo Diaceri; Xavier Quaglia-Thermes; Dominique Mazier; Melody A Swartz; Jeffrey A Hubbell
Journal:  Nat Mater       Date:  2019-01-14       Impact factor: 43.841

Review 6.  Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer.

Authors:  Eden R Padayachee; Fleury Augustin Nsole Biteghe; Zaria Malindi; Dirk Bauerschlag; Stefan Barth
Journal:  Transfus Med Hemother       Date:  2017-09-11       Impact factor: 3.747

7.  In Situ Formation of Polymeric Nanoassemblies Using an Efficient Reversible Click Reaction.

Authors:  Bin Liu; Ruiling Wu; Shuai Gong; Hang Xiao; S Thayumanavan
Journal:  Angew Chem Int Ed Engl       Date:  2020-06-15       Impact factor: 15.336

8.  Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo.

Authors:  John A Zuris; David B Thompson; Yilai Shu; John P Guilinger; Jeffrey L Bessen; Johnny H Hu; Morgan L Maeder; J Keith Joung; Zheng-Yi Chen; David R Liu
Journal:  Nat Biotechnol       Date:  2014-10-30       Impact factor: 54.908

Review 9.  Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms.

Authors:  Rong En Tay; Emma K Richardson; Han Chong Toh
Journal:  Cancer Gene Ther       Date:  2020-05-27       Impact factor: 5.987

Review 10.  Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma.

Authors:  Bo Yu; Delong Liu
Journal:  J Hematol Oncol       Date:  2019-09-10       Impact factor: 17.388

View more
  1 in total

1.  Protein Binding Nanoparticles as an Integrated Platform for Cancer Diagnosis and Treatment.

Authors:  Xuemei Wang; Shengbo Li; Siqi Wang; Shuo Zheng; Zhenbing Chen; Heng Song
Journal:  Adv Sci (Weinh)       Date:  2022-08-18       Impact factor: 17.521

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.